Pharmafile Logo
Pharmafocus logo
Advanced Search

pertuzumab

Showing 5 posts of 5 posts found.

Roche image

New cancer drugs escalate Roche earnings

October 16, 2014
Research and Development, Sales and Marketing Cancer, Herceptin (trastuzumab), Kadcyla, Perjeta, Q3, Roche, ado-trastuzumab emtansine, pertuzumab

Roche’s sales saw solid growth in the first nine months of the year, increased by the firm’s new cancer medicines. …

News
Roche picture

FDA grants Roche’s pertuzumab priority review

February 10, 2012
Sales and Marketing Herceptin, Roche, pertuzumab

The FDA has accepted Roche’s potential breast cancer treatment pertuzumab for appraisal and granted the drug priority review. The proposed …

News
Breast cancer image

Breast cancer treatment – the next advances

February 7, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Afinitor, CDF, Lorena Tonarelli, T-DM1, breast cancer, pertuzumab

When a close member of my family was diagnosed with breast cancer, the doctors didn’t give us much hope. They …

Feature
Roche picture

Roche’s new breast cancer drug succeeds in late-stage trial

December 9, 2011
Research and Development, Sales and Marketing Roche, breast cancer, pertuzumab

Roche’s next generation breast cancer drug pertuzumab has helped patients to live over six months longer. CLEOPATRA, the first randomised …

News
Roche Severin Schwann

Roche weathers tough year and looks to pipeline for 2011

February 3, 2011
Research and Development, Sales and Marketing 2010 pharma results, BRAF protein, GDC-0449, RG3616, RG7204, Roche, avastin, pertuzumab

Roche is looking to its innovative late-stage pipeline to help it get back on track for the next financial year …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025